|
|
|
Volumn 61, Issue 8, 2001, Pages 3285-3289
|
|
Nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NSAIDs) alter the kinetics of human colon cancer cell lines more effectively than traditional NSAIDs: Implications for colon cancer chemoprevention
a,b c b b b a,b,d |
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2 (ACETYLOXY)BENZOIC ACID 4 (NITROOXYMETHYL)PHENYL ESTER;
3 [[4 ALPHA METHYL 4 (2 METHYLPROPYL)BENZENEACETYLOXY] 3 METHOXYPHENYL] 2 PROPENOIC ACID 4 NITROOXYBUTYL ESTER;
5 FLUORO 2 METHYL 1[[4 (METHYLSULFINYL)PHENYL]METHYLENE] 1H INDENE 3 ACETIC ACID 4 NITROOXYBUTYL ESTER;
ACETYLSALICYLIC ACID;
DIMETHYL SULFOXIDE;
IBUPROFEN;
NCX 1102;
NCX 2210;
NCX 4040;
NITRIC OXIDE;
NITRIC OXIDE DONOR;
NONSTEROID ANTIINFLAMMATORY AGENT;
SULINDAC;
UNCLASSIFIED DRUG;
ANALGESIA;
ANTIOXIDANT ACTIVITY;
APOPTOSIS;
ARTICLE;
CELL CYCLE G0 PHASE;
CELL CYCLE G1 PHASE;
CELL CYCLE S PHASE;
CELL KINETICS;
CHEMOPROPHYLAXIS;
COLON CANCER;
CONTROLLED STUDY;
DNA DEGRADATION;
DRUG POTENCY;
DRUG SAFETY;
GROWTH INHIBITION;
HUMAN;
HUMAN CELL;
IC 50;
MITOSIS INHIBITION;
PHASE TRANSITION;
PRIORITY JOURNAL;
ADENOCARCINOMA;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ANTICARCINOGENIC AGENTS;
APOPTOSIS;
ASPIRIN;
CELL CYCLE;
CELL DIVISION;
COLON;
COLONIC NEOPLASMS;
GROWTH INHIBITORS;
HT29 CELLS;
HUMANS;
IBUPROFEN;
NITRIC OXIDE DONORS;
SULINDAC;
TUMOR CELLS, CULTURED;
|
|
EID: 0035870291
PISSN: 00085472
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (143)
|
|
References (15)
|
